It looks like a private company with strong links to India and offices in the US and Mexico. A team of 7 management and 10 advisory doctors. That doesn't diminish it as a competitor but raises questions about funding requirements. I see there is no government backing for the trials they are doing on CV-19.
It looks like a private company with strong links to India and...
-
- There are more pages in this discussion • 15,558 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.0¢ |
Change
-0.045(4.39%) |
Mkt cap ! $1.164B | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.04 | 97.0¢ | $5.200M | 5.175M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 38523 | 98.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 98.5¢ | 29075 | 14 |
View Market Depth
| Last trade - 12.28pm 24/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |